Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
34.64
-3.31 (-8.58%)
Mar 3, 2025, 3:07 PM EST - Market open
PRAX Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Revenue | 8.55 | 2.45 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | 249.53% | - | - | - | - | Upgrade
|
| Cost of Revenue | - | 86.77 | 154.44 | - | - | Upgrade
|
| Gross Profit | 8.55 | -84.32 | -154.44 | - | - | Upgrade
|
| Selling, General & Admin | 56.31 | 42.05 | 59.55 | 47.08 | 16.99 | Upgrade
|
| Research & Development | 152.41 | - | - | 120.26 | 44.98 | Upgrade
|
| Operating Expenses | 208.72 | 42.05 | 59.55 | 167.33 | 61.97 | Upgrade
|
| Operating Income | -200.17 | -126.37 | -213.99 | -167.33 | -61.97 | Upgrade
|
| Interest & Investment Income | - | 3.14 | 1.96 | 2.36 | 0.14 | Upgrade
|
| Other Non Operating Income (Expenses) | 17.35 | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -182.82 | -123.23 | -212.03 | -164.97 | -61.83 | Upgrade
|
| Merger & Restructuring Charges | - | - | -1 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -0.05 | -1 | -2.09 | - | Upgrade
|
| Pretax Income | -182.82 | -123.28 | -214.03 | -167.06 | -61.83 | Upgrade
|
| Income Tax Expense | - | - | - | - | -0.01 | Upgrade
|
| Net Income | -182.82 | -123.28 | -214.03 | -167.06 | -61.82 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 8.5 | Upgrade
|
| Net Income to Common | -182.82 | -123.28 | -214.03 | -167.06 | -70.32 | Upgrade
|
| Shares Outstanding (Basic) | 18 | 7 | 3 | 3 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 18 | 7 | 3 | 3 | 1 | Upgrade
|
| Shares Change (YoY) | 171.55% | 114.58% | 8.58% | 374.34% | 485.12% | Upgrade
|
| EPS (Basic) | -10.21 | -18.69 | -69.65 | -59.03 | -117.86 | Upgrade
|
| EPS (Diluted) | -10.21 | -18.69 | -69.65 | -59.03 | -117.86 | Upgrade
|
| Free Cash Flow | -131.76 | -111.19 | -185.49 | -125.6 | -52.62 | Upgrade
|
| Free Cash Flow Per Share | -7.36 | -16.86 | -60.36 | -44.38 | -88.19 | Upgrade
|
| Gross Margin | 100.00% | - | - | - | - | Upgrade
|
| Operating Margin | -2340.29% | -5164.41% | - | - | - | Upgrade
|
| Profit Margin | -2137.48% | -5037.88% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -1540.48% | -4543.77% | - | - | - | Upgrade
|
| EBITDA | -199.81 | -125.94 | -213.57 | -167.15 | -61.92 | Upgrade
|
| D&A For EBITDA | 0.36 | 0.43 | 0.42 | 0.18 | 0.05 | Upgrade
|
| EBIT | -200.17 | -126.37 | -213.99 | -167.33 | -61.97 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.